Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 9;9(4):e027034.
doi: 10.1136/bmjopen-2018-027034.

Breast and cervical cancer patients' experience in Addis Ababa city, Ethiopia: a follow-up study protocol

Alem Gebremariam  1   2 , Adamu Addissie  2 , Alemayehu Worku  2 , Selamawit Hirpa  2 , Mathewos Assefa  3 , Lydia E Pace  4 , Eva Johanna Kantelhardt  5 , Ahmedin Jemal  6
Affiliations

Breast and cervical cancer patients' experience in Addis Ababa city, Ethiopia: a follow-up study protocol

Alem Gebremariam et al. BMJ Open. .

Abstract

Introduction: Cancer is an emerging public health problem in Ethiopia, with breast and cervical cancers accounting for over half of all newly diagnosed cancers in women. The majority of women with breast and cervical cancer are diagnosed at late stage of the disease and most patients do not receive care consistent with global standards. However, little is known about the health-seeking behaviours, barriers to early detection and treatment, patient-reported outcomes, financial burden and survival of women with breast and cervical cancer in the country. Therefore, this study aims to document the experience of women with breast and cervical cancer from recognition of symptoms to diagnosis, treatment and survivorship/mortality in Addis Ababa city, Ethiopia.

Methods and analysis: A prospective follow-up study using mixed methods (both quantitative and qualitative) will be employed. All women newly diagnosed with breast and cervical cancer from 1 January, 2017 to 30 June 2018 in Addis Ababa will be included in the study. Interviewer-administered questionnaires will be used to collect information about medical consultations after recognition of symptoms, health-seeking behaviours, treatment received, barriers to early detection and treatment, and survivorship care. In-depth interview will be conducted on purposefully selected women with breast and cervical cancer. The primary outcomes of the study are time intervals (patient and diagnostic waiting times), stage at diagnosis and survival. Multivariable analysis will be employed to determine the contributions of independent variables on the outcomes of interest. HRs with 95% CIs will be calculated for time-to-event outcomes. Qualitative data will be analysed using thematic analysis.

Ethics and dissemination: This protocol is ethically approved by Institutional Review Board of Addis Ababa University. Verbal informed consent will be obtained from study participants. Results will be disseminated in international peer-reviewed journals and presented in relevant conferences.

Keywords: addis ababa, ethiopia; breast neoplasm; reported outcome measures; uterine cervical neoplasm.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Torre LA, Islami F, Siegel RL, et al. Global cancer in women: Burden and trends. Cancer Epidemiol Biomarkers Prev 2017;26:444–57. 10.1158/1055-9965.EPI-16-0858 - DOI - PubMed
    1. Kantelhardt EJ, Muluken G, Sefonias G, et al. A review on breast cancer care in Africa. Breast Care 2015;10:364–70. 10.1159/000443156 - DOI - PMC - PubMed
    1. Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012;118:4372–84. 10.1002/cncr.27410 - DOI - PubMed
    1. Timotewos G, Solomon A, Mathewos A, et al. First data from a population based cancer registry in Ethiopia. Cancer Epidemiol 2018;53:93–8. 10.1016/j.canep.2018.01.008 - DOI - PubMed
    1. Kantelhardt EJ, Moelle U, Begoihn M, et al. Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy. Oncologist 2014;19:727–34. 10.1634/theoncologist.2013-0326 - DOI - PMC - PubMed

Publication types